Article Details
Retrieved on: 2025-10-02 22:16:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Shares of the drugmaker were up 1.6% at $139.30 in extended trade. The drug, Zepzelca, in combination with Roche's Tecentriq, is approved for patients ...
Article found on: wiky.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here